The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer

NCT02395640 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

438

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Epirubicin
DRUG: Oxaliplatin
DRUG: Capecitabine

Sponsor

Fudan University